홈
탐색
nav.journalClub
트렌드
더보기
synapse
⌘+K
언어
한국어
한국어
Facilitators and Barriers to Home-Based Long-Acting Injectable Antiretroviral Therapy: Clinician Perspectives from the INVITE-Home Study | Synapse
March 3, 2026
Facilitators and Barriers to Home-Based Long-Acting Injectable Antiretroviral Therapy: Clinician Perspectives from the INVITE-Home Study
AB
Alicia Bolton
University of California, San Francisco
BB
Beth Bourdeau
University of California, San Francisco
JO
Jesse O’Shea
Centers for Disease Control and Prevention
See all
Key Points
Home-based long-acting injectable antiretroviral therapy shows significant facilitators and barriers in implementation.
Clinicians identified communication, training, and patient engagement as critical factors influencing therapy success.
Analysis of clinician perspectives highlighted practical insights into treatment acceptance and retention.
Findings underscore the need for comprehensive training, improved communication strategies, and supportive resources.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Bolton et al. (Wed,) studied this question.
synapsesocial.com/papers/69a75cacc6e9836116a25bd1
https://doi.org/https://doi.org/10.1007/s10461-026-05039-z
Mark Helpful
Like
Save
Bookmark
Relay
Share